CYT, calculated as the geometric mean of GZMA and PRF1 mRNA expression in tissue, generally indicates a stronger anti-tumor immune response and heightened sensitivity to immune checkpoint inhibitors, reflecting the host’s immune status (Rooney et al., 2015). This evidence concerns the gene PRF1 and neoplasm.